Rita Jain is Chief Medical Officer of Immunovant, Inc.. Currently has a direct ownership of 129,365 shares of IMVT, which is worth approximately $3.56 Million. The most recent transaction as insider was on Mar 19, 2021, when has been sold 109,365 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 129K
0% 3M change
0% 12M change
Total Value Held $3.56 Million

Rita Jain Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2021
BUY
Grant, award, or other acquisition
-
109,365 Added 45.81%
129,365 Common Stock
Jan 22 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 50.0%
20,000 Common Stock

Also insider at

CCXI
ChemoCentryx, Inc.
ANAB
ANAPTYSBIO, INC Healthcare
PRVB
Provention Bio, Inc. Healthcare
CLDX
Celldex Therapeutics, Inc. Healthcare
RJ

Rita Jain

Chief Medical Officer
San Carlos, CA

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT